AIM ImmunoTech Inc (AIM)
0.42
0.00 (0.00%)
USD |
NYAM |
Apr 23, 13:49
AIM ImmunoTech Max Drawdown (5Y): 99.76% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.76% |
| February 29, 2024 | 99.76% |
| January 31, 2024 | 99.76% |
| December 31, 2023 | 99.76% |
| November 30, 2023 | 99.76% |
| October 31, 2023 | 99.76% |
| September 30, 2023 | 99.76% |
| August 31, 2023 | 99.76% |
| July 31, 2023 | 99.76% |
| June 30, 2023 | 99.76% |
| May 31, 2023 | 99.76% |
| April 30, 2023 | 99.76% |
| March 31, 2023 | 99.76% |
| February 28, 2023 | 99.76% |
| January 31, 2023 | 99.76% |
| December 31, 2022 | 99.76% |
| November 30, 2022 | 99.76% |
| October 31, 2022 | 99.76% |
| September 30, 2022 | 99.76% |
| August 31, 2022 | 99.76% |
| July 31, 2022 | 99.76% |
| June 30, 2022 | 99.76% |
| May 31, 2022 | 99.76% |
| April 30, 2022 | 99.76% |
| March 31, 2022 | 99.76% |
| Date | Value |
|---|---|
| February 28, 2022 | 99.76% |
| January 31, 2022 | 99.76% |
| December 31, 2021 | 99.76% |
| November 30, 2021 | 99.76% |
| October 31, 2021 | 99.76% |
| September 30, 2021 | 99.76% |
| August 31, 2021 | 99.76% |
| July 31, 2021 | 99.76% |
| June 30, 2021 | 99.76% |
| May 31, 2021 | 99.76% |
| April 30, 2021 | 99.76% |
| March 31, 2021 | 99.76% |
| February 28, 2021 | 99.76% |
| January 31, 2021 | 99.76% |
| December 31, 2020 | 99.76% |
| November 30, 2020 | 99.76% |
| October 31, 2020 | 99.76% |
| September 30, 2020 | 99.76% |
| August 31, 2020 | 99.76% |
| July 31, 2020 | 99.76% |
| June 30, 2020 | 99.76% |
| May 31, 2020 | 99.76% |
| April 30, 2020 | 99.76% |
| March 31, 2020 | 99.76% |
| February 29, 2020 | 99.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.97%
Minimum
Apr 2019
99.76%
Maximum
Nov 2019
99.61%
Average
99.76%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Electromed Inc | 55.84% |
| Xtant Medical Holdings Inc | 98.66% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.45 |
| Beta (5Y) | -0.1013 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 122.9% |
| Historical Sharpe Ratio (5Y) | -0.3563 |
| Historical Sortino (5Y) | -0.9236 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.98% |